Targeting T-cell migration in inflammatory bowel disease.
about
Role of G protein-coupled receptors in control of dendritic cell migrationDesigning biologic selectivity for inflammatory bowel disease--role of vedolizumabPRISMA--efficacy and safety of vedolizumab for inflammatory bowel diseases: a systematic review and meta-analysis of randomized controlled trials.Deficiency of Nuclear Receptor Nur77 Aggravates Mouse Experimental Colitis by Increased NFκB Activity in Macrophages.Effects of vercirnon on the activity of CYP3A4, CYP2C19 and CYP2C8 enzymes and BCRP and OATP1B1 transporters using probe substrates.The histopathologic spectrum of kidney biopsies in patients with inflammatory bowel disease.QSAR methods for the discovery of new inflammatory bowel disease drugs.Immunomodulators in inflammatory bowel disease: an emerging role for biologic agents.Regenerative medicine: prospects for the treatment of inflammatory bowel disease.T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy.Real-time tracking, retrieval and gene expression analysis of migrating human T cells.Degree of colitis correlates with microbial composition and cytokine responses in colon and caecum of Gαi2-deficient mice.Colorectal cancer-infiltrating T lymphocytes display a distinct chemokine receptor expression profile.Gp96 Peptide Antagonist gp96-II Confers Therapeutic Effects in Murine Intestinal Inflammation.CD8αβ+ γδ T Cells: A Novel T Cell Subset with a Potential Role in Inflammatory Bowel Disease.Intestinal T cell profiling in Inflammatory Bowel Disease; linking T cell subsets to disease activity and disease course.
P2860
Q26849785-1D20E71B-A74E-4A48-A9DC-274C8CAEE1B3Q28083872-35E8D12F-E462-4861-9DE5-1B766138AF18Q35530872-2E5A11B0-E915-4AD8-B21E-EF7C91913921Q35737476-B0F71A91-3217-4C90-86C3-8264733DED31Q37469352-9E7C7266-FD13-4751-B012-83D7BCD88481Q37553057-8F1D7CEA-C475-44AD-BCC6-65A2053E997CQ38106116-76305949-2E82-45B7-9903-125EE7EC3E26Q38113159-7011AE5B-DAB7-4268-84F3-8F669063D606Q38133660-F1A5F907-FF03-40CD-A9B2-FB5CF731F980Q38873974-CC906722-0F9A-4929-8009-129B80DEFD79Q40244020-32984CC8-6601-40D2-A8E8-F5DEB1C672ECQ40681075-63E155CE-1A8B-47EA-8866-72F012CD15B0Q42375130-9E684695-4C68-4C78-BCA5-D437F031335DQ47221352-713AF258-11F0-46EE-B2AB-6A8D74832225Q48223755-C5E6C10D-5978-43BB-B2F3-4DC591BC792EQ50049064-E6A9CD47-BA98-4FA1-9F09-5E0C942A904E
P2860
Targeting T-cell migration in inflammatory bowel disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Targeting T-cell migration in inflammatory bowel disease.
@en
type
label
Targeting T-cell migration in inflammatory bowel disease.
@en
prefLabel
Targeting T-cell migration in inflammatory bowel disease.
@en
P2860
P1476
Targeting T-cell migration in inflammatory bowel disease
@en
P2093
P2860
P304
P356
10.1111/J.1365-2796.2012.02588.X
P407
P577
2012-10-15T00:00:00Z